TY - JOUR ID - pittir19856 UR - http://d-scholarship-dev.library.pitt.edu/19856/ IS - 7 A1 - Burnett, JC A1 - Ruthel, G A1 - Stegmann, CM A1 - Panchal, RG A1 - Nguyen, TL A1 - Hermone, AR A1 - Stafford, RG A1 - Lane, DJ A1 - Kenny, TA A1 - McGrath, CF A1 - Wipf, P A1 - Stahl, AM A1 - Schmidt, JJ A1 - Gussio, R A1 - Brunger, AT A1 - Bavari, S Y1 - 2007/02/16/ N2 - An efficient research strategy integrating empirically guided, structure-based modeling and chemoinformatics was used to discover potent small molecule inhibitors of the botulinum neurotoxin serotype A light chain. First, a modeled binding mode for inhibitor 2-mercapto-3-phenylpropionyl-RATKML (K i = 330 nM) was generated, and required the use of a molecular dynamic conformer of the enzyme displaying the reorientation of surface loops bordering the substrate binding cleft. These flexible loops are conformationally variable in x-ray crystal structures, and the model predicted that they were pivotal for providing complementary binding surfaces and solvent shielding for the pseudo-peptide. The docked conformation of 2-mercapto-3-phenylpropionyl- RATKML was then used to refine our pharmacophore for botulinum serotype A light chain inhibition. Data base search queries derived from the pharmacophore were employed to mine small molecule (non-peptidic) inhibitors from the National Cancer Institute's Open Repository. Four of the inhibitors possess Ki values ranging from 3.0 to 10.0 ?M. Of these, NSC 240898 is a promising lead for therapeutic development, as it readily enters neurons, exhibits no neuronal toxicity, and elicits dose-dependent protection of synaptosomal-associated protein (of 25 kDa) in a primary culture of embryonic chicken neurons. Isothermal titration calorimetry showed that the interaction between NSC 240898 and the botulinum A light chain is largely entropy-driven, and occurs with a 1:1 stoichiometry and a dissociation constant of 4.6 ?M. JF - Journal of Biological Chemistry VL - 282 SN - 0021-9258 TI - Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons SP - 5004 AV - public EP - 5014 ER -